PROVIDER INITIATED TEST - The Male Cancer Panel is a blood test that includes three tumor markers commonly used to support the evaluation and monitoring of prostate and gastrointestinal cancers. These tests are most often used to assess treatment response, monitor disease progression, or detect recurrence in individuals with a known cancer diagnosis, rather than for routine cancer screening.
Tumor marker levels can also be influenced by non-cancerous conditions, so results are interpreted alongside clinical findings and additional diagnostic information.
The panel includes 3 tests:
PSA, Total: Measures the total level of prostate-specific antigen to help evaluate prostate health
PSA, Free: Assesses the proportion of free PSA, which can provide additional insight when total PSA is elevated
CA 19-9: Associated with gastrointestinal and pancreatic cancers
Cancer Panel, Male (PSA Free & Total, CA 19-9)
PROVIDER INITIATED TEST - The Male Cancer Panel is a blood test that includes three tumor markers commonly used to support the evaluation and monitoring of prostate and gastrointestinal cancers. These tests are most often used to assess treatment response, monitor disease progression, or detect recurrence in individuals with a known cancer diagnosis, rather than for routine cancer screening.
Tumor marker levels can also be influenced by non-cancerous conditions, so results are interpreted alongside clinical findings and additional diagnostic information.
The panel includes 3 tests:
PSA, Total: Measures the total level of prostate-specific antigen to help evaluate prostate health
PSA, Free: Assesses the proportion of free PSA, which can provide additional insight when total PSA is elevated
CA 19-9: Associated with gastrointestinal and pancreatic cancers
